Pityriasis rubra pilaris following COVID-19 vaccination successfully treated with ixekizumab.

Zhao, Patricia; Rusu, Corina A; Schenck, Olivia L

Zhao, Patricia; Rusu, Corina A; Schenck, Olivia L.

Afiliación

Zhao P; University of Virginia School of Medicine, Charlottesville, Virginia.
Rusu CA; Department of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia.
Schenck OL; Department of Dermatology, University of Virginia Medical Center, Charlottesville, Virginia.

JAAD Case Rep ; 35: 52-56, 2023 May.

Article en En | MEDLINE | ID: mdl-37034027

Palabras clave

COVID-19 vaccine; IL-17 inhibitor; PRP; adverse effect; ixekizumab; pityriasis rubra pilaris; vaccination

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2023 Tipo del documento: Article